Thermo Fisher Scientific, Inc. Share Price
Equities
TMO
US8835561023
Advanced Medical Equipment & Technology
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 572.77 USD | -0.43% |
|
-3.06% | +10.10% |
| 04/12 | GENinCode inks commercialisation deal with Thermo Fisher | AN |
| 04/12 | GENinCode Partners with US-based Thermo Fisher to Commercialize Heart Disease Test | MT |
| Capitalization | 22TCr 18TCr 17TCr 16TCr 30TCr 19,36700Cr 32TCr 2,02700Cr 78TCr 9,14700Cr 81TCr 79TCr 33,44500Cr | P/E ratio 2025 * |
32.1x | P/E ratio 2026 * | 28.9x |
|---|---|---|---|---|---|
| Enterprise value | 24TCr 21TCr 20TCr 18TCr 34TCr 21,87900Cr 37TCr 2,29000Cr 88TCr 10,33300Cr 91TCr 89TCr 37,78300Cr | EV / Sales 2025 * |
5.49x | EV / Sales 2026 * | 5.14x |
| Free-Float |
86.06% | Yield 2025 * |
0.29% | Yield 2026 * | 0.31% |
Last Transcript: Thermo Fisher Scientific, Inc.
| 1 day | -0.43% | ||
| 1 week | -3.06% | ||
| Current month | -3.06% | ||
| 1 month | +1.20% | ||
| 3 months | +16.27% | ||
| 6 months | +42.52% | ||
| Current year | +10.10% |
| 1 week | 560.16 |  | 597.68 |
| 1 month | 556.46 | | 602.32 |
| Current year | 385.46 | | 610.97 |
| 1 year | 385.46 | | 610.97 |
| 3 years | 385.46 | | 627.88 |
| 5 years | 385.46 | | 672.34 |
| 10 years | 119.75 | | 672.34 |
| Manager | Title | Age | Since |
|---|---|---|---|
Marc Casper
CEO | Chief Executive Officer | 57 | 15/10/2009 |
| Director of Finance/CFO | 58 | 01/08/2015 | |
Sebastian Pacios
CTO | Chief Tech/Sci/R&D Officer | - | 01/10/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Scott Sperling
BRD | Director/Board Member | 67 | 09/11/2006 |
Marc Casper
CHM | Chairman | 57 | 26/02/2020 |
Tyler Jacks
BRD | Director/Board Member | 64 | 26/05/2009 |
| Name | Weight | AuM | Varia. Jan 1. | Investor |
|---|---|---|---|---|
 | 7.43% | 26 M€ | +11.73% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.43% | -3.06% | +8.20% | +4.04% | 22TCr | |
| +1.18% | +0.32% | +4.53% | +116.04% | 20TCr | |
| -0.39% | -0.23% | -1.68% | -14.74% | 16TCr | |
| -0.20% | -4.00% | +8.27% | +115.94% | 14TCr | |
| +1.92% | +1.56% | -15.42% | -11.65% | 5.65TCr | |
| +0.48% | -0.55% | +20.49% | +19.26% | 5TCr | |
| -1.91% | -5.22% | +3.49% | -3.87% | 4.12TCr | |
| +3.56% | +6.84% | +5.19% | - | 3.89TCr | |
| +2.00% | +0.28% | +6.27% | +17.83% | 3.74TCr | |
| +1.19% | -0.79% | -22.99% | -37.74% | 3.46TCr | |
| Average | +0.74% | -0.37% | +1.64% | +22.79% | 9.82TCr | |
| Weighted average by Cap. | +0.37% | -1.09% | +3.62% | +40.76% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 4.43TCr 3.8TCr 3.56TCr 3.32TCr 6.14TCr 3,98300Cr 6.67TCr 42TCr 16TCr 1,88100Cr 17TCr 16TCr 6,87800Cr | 4.65TCr 4TCr 3.74TCr 3.49TCr 6.45TCr 4,18500Cr 7.01TCr 44TCr 17TCr 1,97700Cr 17TCr 17TCr 7,22800Cr |
| Net income | 670.7Cr 576.53Cr 540.09Cr 503.4Cr 929.8Cr 60TCr 1.01TCr 6.32TCr 2.44TCr 29TCr 2.52TCr 2.46TCr 1,04200Cr | 738.42Cr 634.75Cr 594.62Cr 554.23Cr 1.02TCr 66TCr 1.11TCr 6.96TCr 2.69TCr 31TCr 2.77TCr 2.71TCr 1,14800Cr |
| Net Debt | 2.79TCr 2.4TCr 2.25TCr 2.1TCr 3.87TCr 2,51200Cr 4.21TCr 26TCr 10TCr 1,18600Cr 10TCr 10TCr 4,33800Cr | 2.37TCr 2.04TCr 1.91TCr 1.78TCr 3.28TCr 2,13100Cr 3.57TCr 22TCr 8.61TCr 1,00700Cr 8.89TCr 8.7TCr 3,68000Cr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 05/25/05 | 572.77 $ | -0.43% | 18,73,706 |
| 04/25/04 | 575.24 $ | -0.90% | 19,61,858 |
| 03/25/03 | 580.45 $ | +0.01% | 11,86,616 |
| 02/25/02 | 580.37 $ | -0.82% | 19,18,180 |
| 01/25/01 | 585.15 $ | -0.96% | 17,54,359 |
Delayed Quote Nyse, December 06, 2025 at 02:30 am IST
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- TMO Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition